Biomaterials Enabling Regenerative Medicine
ViVita’s patented platform technology—the SPEAR Platform—removes the immunological barriers in animal-derived tissues, rendering them immune-compatible with human patients. Leveraging this technology, ViVita aims to generate off-the-shelf tissue and organ replacements that avoid long-term medication, repeat transplants, and associated patient deaths.
who we are
Maelene L. Wong, PhD
Co-Founder & Chief Executive Officer
Maelene leads the effort to translate ViVita's platform technology from the lab bench and commercialize the resultant products for applications in regenerative medicine. She pioneered the ViVita Process as a graduate student to address morbidity and mortality associated with the shortage of donor organs and tissues. Her 16 years of experience in cardiovascular tissue engineering have solidified her desire to generate novel technologies that facilitate the body's return to normal function through tissue engineering and regenerative medicine approaches. Maelene earned her PhD in Biomedical Engineering from UC Davis and her BS in Bioengineering from UC Berkeley.
Jim D. Olson, MBA
Jim possesses over 40 years of experience in leadership roles, founding WestShore Management Group after leading high tech businesses for 2 Fortune 500 companies. He serves as a Business Specialist for the UC Davis Engineering Translational Technology Center (ETTC) and is a Visiting Lecturer at the Graduate School of Management. Jim drives ViVita's business development through strategic advising and connections with investors and key partners.
Leigh G. Griffiths, VetMB, RCVS Diplomate of Small Animal Surgery (Soft Tissue), Diplomate ACVIM (Cardiology), MRCVS, PhD
Co-Founder & Chairman
Leigh graduated from Cambridge University in 1995 and was the first veterinary surgeon in the United Kingdom to train as a microvascular surgeon at the world-renowned Canneisburn Hospital. He completed a fellowship in cardiac surgery at Colorado State University in 2003, followed by a PhD and residency in Cardiology. He joined the faculty at the University of California Davis in 2007, where he runs the cardiovascular surgery program.